Generally, breast cancer can be divided into four types according to the molecular characteristics, including luminal type A, luminal type B, HER2 enriched type, and triple negative type, which could influence the adjuvant treatments and the prognosis of patients (28). Here, ERBB2 is linked to breast carcinoma.